ElectromedELMD +3.09%85 Buyback Yield % is 2.02 as of Jul. 04, 2026, which is 14% above its 10-year median of 1.77. GuruFocus rates ELMD with a GF Score™ of 85/100 and a GF Value™ of $25.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Electromed ranks better than 86.74% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Electromed's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ELMD vs CATX, MASS, CV: Buyback Yield % Comparison
For the Medical Devices subindustry, Electromed's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Electromed's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromed (ELMD) has a Buyback Yield % of 2.02 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Electromed and its competitors. This is 14% above median its historical median of 1.77. Over the past decade, Electromed's Buyback Yield % has ranged from 0.01 to 5.45. According to the industry distribution chart, Electromed ranks #46 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 13.3%.
Is Electromed's Buyback Yield % too high?
Electromed's current Buyback Yield % of 2.02 is 14% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 5.45. Based on the distribution chart, Electromed ranks #46 out of 347 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Electromed has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Buyback Yield % compare to CATX and MASS?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #46 out of 347 companies for Buyback Yield %. This places Electromed in the top 13% of its industry — outperforming the majority of peers. Historically, Electromed's own Buyback Yield % has ranged from 0.01 to 5.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Electromed and its competitors. Electromed's current Buyback Yield % is 2.02, which is 14% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.23, compared to a current price of $45.43 — trading 80.1% above its estimated fair value. The current Buyback Yield % is 2.02, which is 14% above median its 10-year median of 1.77. Electromed's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Electromed (ELMD), the current Buyback Yield % is 2.02 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $45.43 is trading 80.1% above its estimated GF Value™ of $25.23.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
Buyback Yield %: 2.02 (14% above median its 10-year median of 1.77)
GF Value™: $25.23 vs. price of $45.43 (80.1% above fair value)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
85GF Score
Get the complete analysis for ELMD
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
